studi
tri
identifi
dengu
virusspecif
tcell
epitop
induc
pbmc
peripher
blood
mononuclear
cell
isol
df
convalesc
patient
dengu
viru
type
infect
secret
pbmc
df
convalesc
patient
stimul
vitro
dengu
virusderiv
peptid
prepar
base
predict
dengu
virusspecif
tcell
epitop
use
rankpep
onlin
softwar
subsequ
frequenc
produc
cell
percentag
cell
measur
use
elispot
assay
ic
assay
intracellular
cytokin
strain
respect
posit
respons
pbmc
elispot
show
number
sfc
spot
form
cell
rang
pbmc
posit
respons
pbmc
ic
assay
show
percentag
cell
rang
result
c
klvmafiaflrfl
e
ssigkmfeatarg
yrilqrgllgrsq
nregkivglygngvv
identifi
dengu
virusspecif
tcell
epitop
dengu
viru
den
singlestrand
posit
rna
viru
famili
flavivirida
compris
four
distinct
serotyp
within
flaviviru
genu
infect
four
serotyp
dengu
viru
result
asymptomat
infect
selflimit
febril
diseas
dengu
fever
df
sever
lifethreaten
ill
dengu
hemorrhag
fever
dhf
halstead
den
infect
seriou
caus
morbid
mortal
tropic
subtrop
area
world
gubler
gibbon
vaughn
untreat
mortal
rate
dhf
around
reduc
fluid
replac
even
though
previou
studi
suggest
antibodydepend
enhanc
ade
take
part
pathogenesi
dhf
pathogenesi
dhf
entir
explain
antibodi
howev
current
mani
studi
suggest
denguespecif
tcell
immun
respons
hypothes
play
import
role
immunopathogenesi
dhf
secondari
den
viru
infect
induct
immunopatholog
lymphocyt
may
occur
variou
mechan
includ
cellmedi
cytotox
andor
cytokin
product
miskovski
et
al
vergelli
et
al
addit
studi
show
dhf
associ
high
level
tcell
cytokin
evid
mark
tcell
activ
librati
et
al
recent
immunopathogenesi
dhf
propos
evid
denguespecif
lymphocyt
implic
pathogenesi
natur
immun
dengu
virus
lei
et
al
cell
contribut
process
incomplet
defin
howev
sinc
studi
directli
examin
tcell
respons
acut
diseas
denspecif
tcell
epitop
identifi
green
et
al
mongkolsapaya
et
al
therefor
establish
librari
defin
tcell
epitop
dengu
virus
help
explor
role
cell
immun
diseas
pathogenesi
present
studi
combin
bioinformat
tool
epitopepredict
program
rankpep
vitro
assay
enzymelink
immunospot
assay
elispot
intracellular
cytokin
stain
assay
ic
use
screen
select
antigen
sequenc
potenti
denspecif
tcell
epitop
select
sequenc
test
biolog
function
activ
cell
den
infect
popul
total
df
convalesc
patient
enrol
studi
earlyconvalescentphas
den
infect
case
recruit
eighth
peopl
hospit
guangzhou
china
also
includ
three
guangdong
residu
infect
confirm
viru
isol
cell
cultur
subsequ
serotyp
identif
den
serotypespecif
rtpcr
viremiaphas
lanciotti
et
al
addit
den
infect
also
confirm
use
commerci
captureimmunoglobulin
igm
igg
enzymelink
immunosorb
assay
elisa
convalescentphas
describ
previous
kuno
et
al
obtain
inform
consent
peripher
blood
sampl
drawn
prepar
peripher
blood
mononuclear
cell
pbmc
meanwhil
ethic
committe
author
institut
approv
studi
pbmc
isol
peripher
whole
blood
ficollhypaqu
densiti
gradient
centrifug
g
min
c
use
directli
elispot
assay
ic
assay
rankpep
onlin
softwar
http
wwwmifdfciharvard
edutoolsrankpephtml
use
predict
denspecif
tcell
epitop
den
strain
use
predict
process
includ
strain
strain
strain
strain
tabl
follow
criteria
use
select
candid
denspecif
tcell
epitop
higher
rank
score
rankpep
predict
predict
epitop
highli
conserv
select
den
strain
four
higherrank
candid
tcell
epitop
c
e
synthes
use
carbonylbas
solidphas
chemistri
multipl
peptid
synthes
puriti
pure
huachen
compani
xian
china
coincid
actual
molecular
mass
theoret
molecular
mass
confirm
mass
spectrographi
analysi
peptid
dissolv
phosphatebuff
salin
pb
dilut
mgml
pb
store
c
subsequ
elispot
assay
ic
assay
sequenc
inform
peptid
detail
tabl
assay
perform
use
human
elispot
kit
r
system
minneapoli
mn
follow
protocol
provid
manufactur
briefli
polyvinyliden
difluorideback
plate
precoat
monoclon
antibodi
block
l
steril
medium
contain
mm
lglutamin
uml
penicillin
gml
streptomycin
heatinactiv
fetal
calf
serum
min
room
temperatur
total
pbmc
ad
l
medium
per
well
individu
peptid
subsequ
ad
final
concentr
gml
unstimul
phytohemagglutinin
pha
gml
stimul
cell
serv
neg
posit
control
respect
addit
sarscov
peptid
sever
acut
respiratori
syndromecoronari
viru
shvplatsrtla
use
irrelev
peptid
control
overnight
incub
c
co
air
plate
wash
pb
contain
next
biotinyl
antibodi
ad
overnight
incub
c
plate
wash
incub
h
room
temperatur
dilut
streptavidinalkalin
phosphatas
four
final
wash
plate
develop
lwell
alkalin
phosphatas
substrat
nitroblu
tetrazolium
substrat
bcipnbt
chromogen
h
room
temperatur
protect
light
color
develop
monitor
stop
wash
water
dri
overnight
room
temperatur
sfc
spot
form
cell
per
well
count
use
elispot
reader
beij
sagecr
scienc
co
ltd
china
deepbrowncolor
spot
decreas
densiti
radiat
center
count
express
respond
cell
pbmc
assay
consid
valid
posit
control
well
show
pbmc
neg
control
well
show
pbmc
posit
respons
peptid
defin
pbmc
subtract
background
describ
previous
simmon
et
al
pbmc
resuspend
medium
use
directli
ic
assay
previous
describ
moth
et
al
briefli
test
contain
pbmc
incub
either
peptid
sarscov
peptid
irrelev
peptid
control
gml
stimul
peptid
control
h
c
co
meanwhil
brefeldin
bfa
gml
biolegend
inc
ca
ad
cell
wash
use
pb
stain
use
pelabel
apclabel
antibodi
biolegend
inc
ca
min
c
subsequ
cell
fix
paraformaldehyd
permeabil
saponin
stain
use
fluorescein
isothiocyan
fitc
label
antibodi
biolegend
inc
ca
data
acquisit
perform
fac
calibur
flow
cytomet
bd
bioscienc
use
cellquest
softwar
number
event
collect
sampl
vari
depend
donor
cell
gate
analyz
cytokin
express
peptidespecif
cell
defin
cell
octob
januari
recruit
convalesc
patient
dengu
viru
type
infect
mean
age
year
rang
year
mean
time
discharg
draw
blood
sampl
day
rang
day
characterist
studi
popul
detail
tabl
posit
control
assay
show
number
sfc
rang
pbmc
neg
control
unstimul
pbmc
show
number
sfc
df
convalesc
patient
identifi
one
individu
peptid
reproduc
induc
respons
elispot
assay
exceed
pbmc
total
cell
df
convalesc
patient
recogn
four
differ
peptid
magnitud
respons
individu
peptid
rang
sfumillion
pbmc
breadth
respons
individu
patient
rang
peptid
addit
mean
number
spot
obtain
individu
c
irrelev
peptid
e
total
four
peptid
denspecif
tcell
epitop
summari
individu
peptid
reproduc
induc
respons
elispot
assay
provid
fig
level
circul
cell
patient
rang
level
circul
cell
rang
ratio
one
vari
tabl
subject
cell
peptid
control
irrelev
peptid
control
identifi
individu
epitop
produc
evok
cell
ic
assay
exceed
cell
less
equal
cell
consid
neg
posit
respons
pbmc
show
percentag
cell
rang
see
fig
percentag
cell
data
shown
addit
respons
peptid
seen
pbmc
donor
data
shown
result
c
e
denspecif
tcell
epitop
see
fig
initi
viral
tcell
epitop
identifi
either
sequenc
elut
peptid
bound
mhc
molecul
major
histocomp
complex
screen
panel
overlap
peptid
deriv
viral
protein
howev
two
method
shortcom
former
cumbersom
need
sophist
equip
mass
spectromet
peptid
sequenc
latter
need
synthesi
seri
overlap
peptid
massiv
experi
identifi
peptid
epitop
make
extens
timeconsum
process
drabner
et
al
present
novel
strategi
util
computerbas
tcell
epitop
predict
method
combin
vitroin
vivo
studi
establish
predict
potenti
tcell
epitop
becom
increasingli
popular
amino
acid
sequenc
pathogen
protein
avail
databas
huang
et
al
epitopepredict
program
rankpep
develop
molecular
immunolog
foundat
pa
rech
et
al
use
posit
specif
score
matric
pssm
cleavag
model
predict
mhc
bind
peptid
input
protein
base
similar
set
peptid
known
bind
given
mhc
molecul
rech
et
al
among
epitopespredict
program
rankpep
predict
algorithm
higher
sensit
specif
repres
quick
effect
way
identifi
tcell
epitop
drabner
et
al
gomeznunez
et
al
rech
et
al
rech
et
al
recent
elispot
assay
ic
assay
extens
use
measur
frequenc
memori
cell
compar
vitro
method
elispot
assay
ic
assay
higher
sensit
latter
advantag
defin
phenotyp
cytokin
secret
cell
waldrop
et
al
butz
bevan
pala
et
al
therefor
combin
elispot
assay
ic
assay
necessari
identifi
tcell
epitop
date
studi
identifi
denspecif
tcell
epitop
mainli
locat
protein
c
protein
fig
frequenc
cell
pbmc
subject
number
upper
right
hand
corner
panel
indic
cell
percentag
cell
data
acquisit
perform
fac
calibur
flow
cytomet
bd
bioscienc
use
cellquest
softwar
number
event
collect
sampl
vari
depend
donor
cell
gate
analyz
cytokin
express
kuran
et
al
kuran
et
al
gagnon
et
al
mangada
et
al
howev
epitop
conserv
epitop
highli
conserv
identifi
furthermor
low
sensit
methodstechnolog
limit
dilut
method
cytotox
assay
limit
gener
laboratori
identifi
tcell
epitop
studi
measur
higher
frequenc
den
peptidespecif
respond
cell
use
elispot
assay
ic
assay
identifi
four
denspecif
tcell
epitop
importantli
among
df
convalesc
patient
peptid
breadth
posit
respons
rang
subject
suggest
epitop
could
immunodomin
epitop
restrict
highfrequ
hla
allel
human
popul
cours
futur
experi
would
perform
determin
hla
restrict
epitop
among
four
epitop
c
contain
sequenc
previous
character
denspecif
tcell
epitop
c
respect
kuran
et
al
gagnon
et
al
therefor
result
indic
c
could
minim
sequenc
recogn
mhcii
molecul
interestingli
previous
identifi
epitop
kuran
et
al
put
hla
allel
rankpep
addit
c
epitop
gagnon
et
al
restrict
hla
allel
c
rankpep
includ
therefor
inform
suggest
restrict
hla
allel
c
could
close
relat
respect
studi
e
two
novel
identifi
tcell
epitop
sinc
e
protein
import
structur
protein
den
infect
immun
research
aim
identifi
tcell
epitop
locat
protein
defin
tcell
epitop
simmon
et
al
bashyam
et
al
howev
knowledg
e
first
tcell
epitop
identifi
human
popul
importantli
e
highli
conserv
strain
therefor
identif
e
would
help
explor
role
tcell
immun
respons
induc
e
protein
den
infect
immun
previou
studi
shown
protein
appear
immunogen
antigen
cellular
respons
den
exist
mani
tcell
epitop
mathew
et
al
consequ
research
focus
identifi
tcell
epitop
locat
region
kuran
et
al
kuran
et
al
studi
identif
suggest
region
could
also
contribut
tcell
immun
respons
conclus
studi
indic
good
correl
experiment
observ
comput
predict
peptid
therefor
combin
bioinformat
tool
vitro
assay
better
strategi
identif
tcell
epitop
